Sierra Legacy Group Grows Holdings in Agilent Technologies, Inc. $A

Sierra Legacy Group raised its stake in Agilent Technologies, Inc. (NYSE:A) by 63.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,780 shares of the medical research company’s stock after buying an additional 4,175 shares during the period. Sierra Legacy Group’s holdings in Agilent Technologies were worth $1,272,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Stone House Investment Management LLC bought a new position in Agilent Technologies in the first quarter valued at $30,000. Ransom Advisory Ltd purchased a new position in shares of Agilent Technologies in the 1st quarter worth about $32,000. Central Pacific Bank Trust Division bought a new position in shares of Agilent Technologies during the 2nd quarter valued at about $33,000. Zions Bancorporation National Association UT bought a new position in shares of Agilent Technologies during the 1st quarter valued at about $38,000. Finally, Costello Asset Management INC purchased a new position in shares of Agilent Technologies during the 1st quarter valued at about $47,000. 87.41% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have issued reports on A shares. Rothschild & Co Redburn started coverage on Agilent Technologies in a research note on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price for the company. Evercore ISI increased their target price on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a report on Tuesday, October 7th. Wells Fargo & Company lifted their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, September 15th. Barclays upped their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research report on Thursday, October 2nd. Finally, TD Cowen lifted their price objective on Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $149.62.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 12,490 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the transaction, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. The trade was a 27.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.26% of the company’s stock.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock opened at $143.86 on Wednesday. The company’s fifty day simple moving average is $138.31 and its two-hundred day simple moving average is $124.52. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The firm has a market cap of $40.78 billion, a PE ratio of 33.77, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.37. The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. Agilent Technologies’s revenue for the quarter was up 10.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.